Show Notes
Effective patient and public involvement (PPI) is crucial to conducting research that meets the needs and values of patients. In this podcast, we hear from a team of researchers and people with lived experience about getting involved in the AVATAR2 trial. This study is investigating the effects of digital avatar therapy in people with psychosis who hear voices. We hear about how PPI makes a difference, what getting involved entails, and how people with lived experience shaped the questions, methods, conduct and analysis of the trials.
This podcast was created for the NHS Research Scotland Mental Health Network's Annual Scientific Meeting, 30th October 2023 in Glasgow. Hosted on Acast. See acast.com/privacy for more information.
More from The Mental Elf
Professor Eileen Joyce and Professor Trevor Robbins, two of her closest colleagues and former PhD students, join André Tomlin to remember Professor Susan (Sue) Iversen (1940–2025), the scientist who fused psychopharmacology and neuropsychology and helped found the field of neuropsychopharmacology.
Depression is not one thing, and treating it as if it were may be why so many people don't get better. In this episode, Prof Brenda Penninx offers a sharper way to think about it.
Catherine Harmer, Professor of Cognitive Neuroscience at Oxford and outgoing president of the British Association of Psychopharmacology (BAP), and Naomi Fineberg, Professor of Psychiatry at the University of Hertfordshire and incoming BAP president, discuss how BAP brings together non-clinical scientists, experimental medicine researchers, clinicians, and industry to translate discoveries into patient care.
Oxford psychologist Dr Lucy Foulkes discusses myths and research around adolescent mental health ahead of her public lecture at the British Association of Psychopharmacology Conference (Sunday, 19 July).
Five years of research. 14,000 students surveyed. Interventions tested. A whole-university framework developed. Now: what needs to change?